Lysosomal enzyme delivery by ICAM-1-targeted nanocarriers bypassing glycosylation- and clathrin-dependent endocytosis

This publication has 38 references indexed in Scilit:

• ICAM-1 recycling in endothelial cells: a novel pathway for sustained intracellular delivery and prolonged effects of drugs
  Blood, 2005
• Polymer nanocarriers protecting active enzyme cargo against proteolysis
  Journal of Controlled Release, 2004
• The cell biology of lysosomal storage disorders
  Nature Reviews Molecular Cell Biology, 2004
• ICAM-1: targeted docking for exogenous as well as endogenous ligands
  Advanced Drug Delivery Reviews, 2004
• Dexamethasone-Mediated Up-Regulation of the Mannose Receptor Improves the Delivery of Recombinant Glucocerebrosidase to Gaucher Macrophages
  The Journal of Pharmacology and Experimental Therapeutics, 2004
• Interactions of acid sphingomyelinase and lipid bilayers in the presence of the tricyclic antidepressant desipramine
  FEBS Letters, 2004
• Enzyme replacement therapy: conception, chaos and culmination
  Philosophical Transactions Of The Royal Society B-Biological Sciences, 2003
• The Tricyclic Antidepressant Desipramine Causes Proteolytic Degradation of Lysosomal Sphingomyelinase in Human Fibroblasts
  Biological Chemistry Hoppe-Seyler, 1994
• Immunotargeting of daunomycin to localized and metastatic human colon adenocarcinoma in athymic mice
  Cancer Immunology, Immunotherapy, 1992
• Biosynthesis of lysosomal hydrolases: their synthesis in bound polysomes and the role of co- and post-translational processing in determining their subcellular distribution
  The Journal of cell biology, 1982